Viatris | 销售和管理费用



Selling And Administration Expenses 更改 日
Adcock Ingram Holdings ZAR 1.05B 50.17M 2024-12
Celltrion KRW 276.8B 58.09B 2025-03
Cspc Pharmaceutical CNY 2.1B 22.82M 2024-09
Dianthus Therapeutics USD 6.83M 287K 2024-12
Divis Laboratories Ltd 3.41B 440M 2025-03
Kangmei Pharma CNY 209.56M 118.34M 2025-03
Knight Therapeutics CAD 25.48M 119K 2024-09
Laboratorios Farma EUR 32.57M 26.69M 2024-06
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 12.94M 5.87M 2024-12
Neuren Pharmaceuticals AUD 2.33M 47K 2024-12
Organigram Holdings CAD 17.19M 2.88M 2024-12
Pharma Mar EUR 13.68M 450K 2025-03
Qiagen NV USD 137.94M 3.77M 2025-03
Sartorius EUR 231.9M 13.6M 2025-03
Sino Biopharmaceutical CNY 5.31B 1.89B 2024-12
Tilray USD 72.38M 4.99M 2024-11
Viatris USD 817.5M 65.2M 2025-03
Zz Pientze Pharmaceu 171.29M 130.03M 2025-03



Viatris 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Jun 2025.